Hao Pan's Transactions at Orion Corporation
Orion Corporation has disclosed important information under the Market Abuse Regulation (EU) No 596/2014 regarding transactions involving shares and linked securities conducted by managers and their closely associated individuals.
Overview of Managers' Transactions
Person subject to the notification requirement:
Name: Hao Pan
Position: Other senior manager
Issuer: Orion Oyj
LEI: 74370029VAHCXDR7B745
Notification type: INITIAL NOTIFICATION
Reference number: 74512/4/4
Details of the Transaction
Transaction date: Date of transaction
Venue: XLOM
Instrument type: SHARE
ISIN: FI0009014377
Nature of transaction: DISPOSAL
Breakdown of the Transaction
Volume: 1488
Unit price: 46.15 EUR
Aggregated transactions:
Volume: 1488
Volume weighted average price: 46.15 EUR
About Orion Corporation
Orion is a Finnish pharmaceutical company with a global presence, dedicated to enhancing well-being for over a century. We specialize in the development, manufacturing, and marketing of both human and veterinary pharmaceuticals, as well as active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines, alongside consumer health products. Our pharmaceutical research and development primarily focuses on oncology and pain management. The proprietary products developed by Orion are utilized to treat various conditions, including cancer, neurological disorders, and respiratory issues. In 2023, Orion's net sales reached EUR 1,190 million, and the company employed approximately 3,600 individuals by the year's end. Orion's A and B shares are traded on Nasdaq Helsinki.
Frequently Asked Questions
What is the purpose of the Market Abuse Regulation?
The Market Abuse Regulation is designed to maintain market integrity and protect investors by preventing and penalizing market abuse.
Who is Hao Pan?
Hao Pan serves as a senior manager at Orion Corporation and is involved in significant transactions pertaining to the company's shares.
What type of transaction did Hao Pan conduct?
Hao Pan executed a share disposal transaction, which means he sold shares of Orion Corporation.
What is Orion Corporation's core focus?
Orion Corporation primarily concentrates on developing and marketing pharmaceuticals, especially in the fields of oncology and pain management.
Where can I find more information about Orion Corporation?
For additional information about Orion Corporation, you can visit their official website and explore their communication channels.